Shanghai HeartCare Schedules 31 August 2026 Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend

Bulletin Express

Aug 19

Shanghai HeartCare Medical Technology Corporation Limited will convene its Board of Directors on 31 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend.

The meeting notice, dated 19 August 2026 and signed by Chairman Wang Guohui, confirms that both the financial statements and any potential dividend proposal will be released following Board approval.

Board composition currently includes three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), two non-executive directors (Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).

Shanghai HeartCare is incorporated in the People’s Republic of China as a joint-stock company and its shares trade on the Hong Kong Stock Exchange under the name HEARTCARE-B (stock code: 06609).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1189661659"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189661659\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189661659?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189661659","market":"us","top_or_hot":-1,"title":"Shanghai HeartCare Schedules 31 August 2026 Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>Shanghai HeartCare Medical Technology Corporation Limited will convene its Board of Directors on 31 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend.</p>\n<p>The meeting notice, dated 19 August 2026 and signed by Chairman Wang Guohui, confirms that both the financial statements and any potential dividend proposal will be released following Board approval.</p>\n<p>Board composition currently includes three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), two non-executive directors (Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).</p>\n<p>Shanghai HeartCare is incorporated in the People’s Republic of China as a joint-stock company and its shares trade on the Hong Kong Stock Exchange under the name HEARTCARE-B (stock code: 06609).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai HeartCare Schedules 31 August 2026 Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai HeartCare Schedules 31 August 2026 Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-19 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai HeartCare Medical Technology Corporation Limited will convene its Board of Directors on 31 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend.</p>\n<p>The meeting notice, dated 19 August 2026 and signed by Chairman Wang Guohui, confirms that both the financial statements and any potential dividend proposal will be released following Board approval.</p>\n<p>Board composition currently includes three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), two non-executive directors (Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).</p>\n<p>Shanghai HeartCare is incorporated in the People’s Republic of China as a joint-stock company and its shares trade on the Hong Kong Stock Exchange under the name HEARTCARE-B (stock code: 06609).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06609","symbol_name":"心玮医疗-B","start_time":0,"source_url":"","article_id":"1189661659","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189661659","pubTimestamp":1787130395,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai HeartCare Medical Technology Corporation Limited will convene its Board of Directors on 31 August 2026 to review and approve the consolidated interim results for the six months ended 30 June...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06609":"心玮医疗-B"},"translate_title":"上海心脏计划于 2026 年 8 月 31 日召开董事会会议，批准 2026 年上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06609":1},"content_text":"Shanghai HeartCare Medical Technology Corporation Limited will convene its Board of Directors on 31 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend.\nThe meeting notice, dated 19 August 2026 and signed by Chairman Wang Guohui, confirms that both the financial statements and any potential dividend proposal will be released following Board approval.\nBoard composition currently includes three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), two non-executive directors (Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).\nShanghai HeartCare is incorporated in the People’s Republic of China as a joint-stock company and its shares trade on the Hong Kong Stock Exchange under the name HEARTCARE-B (stock code: 06609).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}